Market Research Logo

CNS/Neurology Market Research Reports & Industry Analysis

Neurology and the CNS is the branch of science dealing with anatomy, function, diagnosis and treatment of disorders and disease affecting the central nervous system (brain and spinal cord). Neuroscience medicine includes but is not limited to the study and treatment of Alzheimer’s disease, major depressive disorder, schizophrenia, Parkinson’s disease, epilepsy/seizures, migraine, insomnia/sleep disorders, bipolar disorder, and ADHD.

A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.

Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.

...Show More ...Show Less


Filter your search

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

CNS/Neurology Industry Research & Market Reports

  • Brain Hemorrhage-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Brain Metastasis-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Cluster Headache Syndrome-Pipeline Insights, 2016

    ...stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ... Read More

  • Cognitive Impairment Associated With Schizophrenia (CIAS)-Pipeline Insights, 2016

    ...covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, ... Read More

  • Diabetic Neuropathy-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Guillain-Barre Syndrome-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Recurrent Malignant Glioma-Pipeline Insights, 2016

    ...stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ... Read More

  • Diabetic Peripheral Neuropathy-Pipeline Insights, 2016

    ...stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ... Read More

  • Brain Derived Neurotrophic Factor (BDNF) Modulators -Pipeline Insights, 2016

    ...Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, ... Read More

  • Down Syndrome-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Drug Addiction-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Fibromyalgia-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Metastatic Brain Tumor-Pipeline Insights, 2016

    ...stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ... Read More

  • Neuroblastoma-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Panic Disorders-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Ataxia-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Psychosis-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Tourette Syndrome-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Traumatic Brain Injury-Pipeline Insights, 2016

    ...stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ... Read More

  • Treatment Resistant Depression-Pipeline Insights, 2016

    ...stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ... Read More

  • Bipolar Disorder (Manic Depression)-Pipeline Insights, 2016

    ...in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ... Read More

  • Brain Injury-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Brain Ischemia-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Brain Tumor-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Cognitive Disorders-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

1 2 4 6 7 8 9 10